Dr. Stacy Donlon, MD

Dr. Stacy Donlon, MD is the Medical Director of the Multiple Sclerosis Encouragement.

In her capacity as Medical Director, Dr. Donlon will be advising the MSEO on medical issues relating to Multiple Sclerosis and will have input as to the programs and services being offered by the MSEO. In addition, she will be a frequent contributor to the MSEO website where she will offer informational articles relating to various topics in MS.

stacy

Specialty

Neuroimmunology and Multiple Sclerosis

Medical School

New York Medical College

Residency

Barrow Neurological Institute

Fellowship

Barrow Neurological Institute

BIOGRAPHY

Stacy Donlon, MD is a fellowship-trained and board certified neurologist specializing in neuroimmunology and multiple sclerosis. 

Dr. Donlon received her fellowship training in Neuroimmunology from Barrow Neurological Institute. In addition, she completed his residency at Barrow Neurological Institute, where she was appointed Chief Resident. he completed an internship in Internal Medicine from Drexel University College of Medicine in Pennsylvania. She obtained her medical degree from New York College of Medicine. Dr. Donlon earned her graduate degree from the University of Pennsylvania and bachelor’s degree from Dickinson College. 

Dr. Donlon is a member of the American Medical Association (AMA) and the American Academy of Neurology (AAN). She remains active in academics through ongoing presentations, publications and clinical research.

Education

  • Undergraduate: Dickinson College
  • Medical School: New York Medical College
  • Advanced Degree: University of Pennsylvania
  • Residency: Barrow Neurological Institute
  • Internship: Drexel University College of Medicine
  • Fellowship: Barrow Neurological Institute

Primary Areas of Interest

  • Neuro-immunology
  • Multiple Sclerosis

Research & Experience

Publications

Chennathukuzhi V, Stein JM, Abel T, Donlon S, Yang S, Miller JP, Allman DM, Simmons RA, Hecht NB. Mice deficient for testis-brain RNA-binding protein exhibit a coordinate loss of TRAX, reduced fertility, altered gene expression in the brain, and behavioral changes. Mol Cell Biol. 2003 Sep;23(18):6419-34. PubMed PMID: 12944470; PubMed Central PMCID: PMC193699.Lee SW, Donlon S, Caplan JP. Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) or Hashimoto's encephalopathy: a case and review.  Psychosomatics. 2011 Mar-Apr;52(2):99-108. doi: 10.1016/j.psym.2010.12.010. PubMed PMID: 21397101.

Presentations

Chennathukuzhi V, Bray, JD, Donlon S, and NB Hecht. Association of a Novel Kinesin Family Protein with TB-RBP. American Society of Andrology Annual Testis Workshop 2003, Phoenix, AZ Donlon S, Schusse C, Kelly K, and Steve Chung. Efficacy of Lacosamide as an Adjunctive Therapy in Patients with Partial Epilepsy - The First Year Experience. . American Academy of Neurology Annual meeting Spring 2011, Honolulu, HI Schusse C, Kelly K, Donlon S, and Steve Chung. Retention Rate of Lacosamide in Comparison to other newer anticonvulsants. American Academy of Neurology Annual meeting Spring 2011, Honolulu, HI 

Kelly K, Donlon S, Schusse C, and Steve Chung. Differences in Tolerability and Discontinuation Rate of Lacosamide among Patients with or without Concurrent Sodium Channel Blocking AEDs. American Academy of N Neurology Annual meeting Spring 2011, Honolulu, HI

Disclaimer: The Multiple Sclerosis Encouragement Organization (MSEO) provides no compensation to Dr. Stacy Donlon, MD for her role as Senior Medical Director nor does the MSEO receive any financial compensation from Dr. Stacy Donlon, MD. Her association with the MSEO is on a volunteer basis.